4D Molecular Therapeutics Insider Trades

FDMT

Track insider trading activity from 4D Molecular Therapeutics executives and directors. See which insiders are buying and selling FDMT stock.

Trades Last 12 Months

FDMT Price

All Insider Trades for 4D Molecular Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bizily Scott Chief Legal Officer
Holding Value $2.07M 217,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.14M 217,000 shares
$9.88
$9.53
Kirn David Chief Executive Officer
Holding Value $7.15M 750,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.41M 750,000 shares
$9.88
$9.53
Holding Value $2.09M 219,000 shares
Last Trade
Mar 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.16M 219,000 shares
$9.88
$9.53
Gupta Ashoo Vp, Finance And Controller
Holding Value $450k 47,224 shares
Last Trade
Mar 20, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.35k 1,086 shares
$8.61
$9.53
Sblendorio Glenn Director
Holding Value $0 0 shares
Last Trade
Jan 05, 2026 Sale
$88.9k 11,250 shares
$7.90
$9.53
Theuer Charles Director
Holding Value $0 0 shares
Last Trade
Dec 12, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$101k 9,333 shares
$10.84
$9.53
Holding Value $214k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$9.53
Chacko Jacob Director
Holding Value $214k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$9.53
Gray Susannah Director
Holding Value $214k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$9.53
Milligan John F Director
Holding Value $322k 33,750 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 33,750 shares
$4.15
$9.53
Tomasello Shawn Director
Holding Value $214k 22,500 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.4k 22,500 shares
$4.15
$9.53
Kim Robert Young Chief Medical Officer
Holding Value $880k 92,300 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$382k 92,300 shares
$4.14
$9.53
Kamal Fariborz President & COO
Holding Value $1.7M 178,400 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$739k 178,400 shares
$4.14
$9.53
Mehra Uneek See Remarks
Holding Value $1.24M 130,000 shares
Last Trade
Mar 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$538k 130,000 shares
$4.14
$9.53
Holding Value $34.4M 3,610,000 shares
Last Trade
Dec 09, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.84M 535,000 shares
$7.18
$9.53
Holding Value $40.5M 4,247,914 shares
Last Trade
Jan 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.5M 540,000 shares
$19.53
$9.53
Holding Value $214k 22,500 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 22,500 shares
$17.98
$9.53
Moretti August J Chief Financial Officer
Holding Value $105k 11,045 shares
Last Trade
May 15, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$53.5k 3,000 shares
$17.82
$9.53
Fishman Robert S Chief Medical Officer
Holding Value $572k 60,000 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$482k 60,000 shares
$8.04
$9.53
Holding Value $214k 22,500 shares
Last Trade
May 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 22,500 shares
$7.77
$9.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up